Cart
sales@molnova.com
ZT-1a
CAS No. 212135-62-1
ZT-1a( —— )
Catalog No. M35128 CAS No. 212135-62-1
ZT-1a is a SPAK inhibitor.ZT-1a inhibits SPAK.ZT-1a can be used for the prevention and treatment of neurodegenerative and neurocognitive disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 181 | In Stock |
|
| 5MG | 275 | In Stock |
|
| 10MG | 455 | In Stock |
|
| 25MG | 771 | In Stock |
|
| 50MG | 1067 | In Stock |
|
| 100MG | 1404 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZT-1a
-
NoteResearch use only, not for human use.
-
Brief DescriptionZT-1a is a SPAK inhibitor.ZT-1a inhibits SPAK.ZT-1a can be used for the prevention and treatment of neurodegenerative and neurocognitive disorders.
-
DescriptionZT-1a is a potent, non-ATP-competitive and selective SPAK inhibitor. ZT-1a inhibits SPAK activity with IC50s of 44.3, 35.0, 46.7 μM at ATP concentrations of 0.01, 0.1 and 1 mM, respectively.
-
In Vitro——
-
In VivoAnimal Model:Naive mice Dosage:10, 30, 50, and 100?mg/kg Administration:Intraperitoneal (i.p.) administration Result:Inhibited SPAK-dependent cation-Cl- cotransporters (CCC) phosphorylation in vivo.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number212135-62-1
-
Formula Weight445.73
-
Molecular FormulaC22H15Cl3N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (224.35 mM; Ultrasonic )
-
SMILESCc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(Cl)ccc1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jinwei Zhang, et al. Modulation of Brain cation-Cl- Cotransport via the SPAK Kinase Inhibitor ZT-1a. Nat Commun. 2020 Jan 7;11(1):78.?
molnova catalog
related products
-
8-Fluoro-1345-tetrah...
8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one
-
YAP/TAZ inhibitor-1
YAP/TAZ inhibitor-1 is a YAP/TAZ inhibitor (IC50 <0.100 μΜ) for the study of abnormal immune function and cancer.
-
PF-04753299
PF-04753299 is a potent and selective inhibitor of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) .
